Drawing for T BD PHARMATECH

USPTO serial 79390081

T BD PHARMATECH

Reviewed by CopyMark Law Group

Status 774
Filing date
Status date
Registration date
—
Examiner
IM, JEAN H
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with T BD PHARMATECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

EE MING TRACEY BAHK

EE MING TRACEY BAHK OLIFF PLCP.O. BOX 320850ALEXANDRIA, VA 22320-4850UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical compounds and intermediates being chemical compounds, obtained by biotechnological processes for use in industry; biological preparations for use in industry and science; chemicals used in industry and science; chemicals for use in biotechnological product development; chemical diagnostic reagents for industrial purposes; reagents for scientific purposes; heat stable polymerase being biochemical preparations for use in industry and science; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; all aforementioned goods are not related with dietary, nutritional, vitamin supplements and preparations and vitaminsACTIVE—
005Pharmaceuticals, medical and veterinary preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; sanitary preparations for medical purposes; material for stopping teeth, dental wax; disinfectants; vermin repelling preparations; fungicides, herbicides; medical and veterinary biological preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; biological reagents for veterinary use; biological reagents for medical use; enzymes for medical purposes; enzymes for veterinary purposes; medicinal active substances with incorporated intermediates, being medical preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; veterinary active substances with incorporated intermediates, being veterinary preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; diagnostic chemical reagents for medical use; diagnostic chemical reagents and media used in veterinary medicine; veterinary analysis reagents; medical analytical reagents; all aforementioned goods are not related with dietary, nutritional, vitamin supplements and preparations and vitaminsACTIVE—
035Retail and wholesale store services for third parties of medical, veterinary, pharmaceutical, biotechnological chemicals and biopreparations used in industry and science, including via the internet; demonstration of goods; advertising services; business administration; all aforementioned services are not related with dietary, nutritional, vitamin supplements and preparations and vitaminsACTIVE—
042Scientific research; advisory services relating to scientific research; scientific and technological services, namely research and design in the field of organic and analytical chemical preparations and design of chemical processes; industrial analysis of chemicals and research as a service in the field of organic and analytical chemistry; quality control for others; biotechnological studies related to chemical active substances and compounds and their intermediates; product research and development; biochemical research and development; biotechnology research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026RFNTREFUSAL PROCESSED BY IB—
May 3, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Apr 29, 2026OP.IOPPOSITION INSTITUTED NO. 999999—
Apr 28, 2026OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Apr 28, 2026OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Apr 22, 2026WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Apr 22, 2026WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Dec 3, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 2, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 2, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 2, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 2, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 10, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 10, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 4, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 4, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 4, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2025DOCKASSIGNED TO EXAMINER—
Feb 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2024RFNTREFUSAL PROCESSED BY IB—
Aug 2, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 2, 2024RFRRREFUSAL PROCESSED BY MPU—
Jul 11, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 10, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2024DOCKASSIGNED TO EXAMINER—
Feb 27, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 23, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 22, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance